Literature DB >> 6789634

Progressive systemic sclerosis subgroups: variable pulmonary features.

V J Taormina, W T Miller, W B Gefter, D M Epstein.   

Abstract

Evidence has accumulated which enables subdivision of progressive systemic sclerosis (scleroderma) into three categories: (1) classic progressive systemic sclerosis (PSS); (2) the CRST/CREST syndrome; or (3) overlap syndromes. Previous reports of the chest film manifestations of PSS have used only the broad category of scleroderma without subdivision. This study analyzed the chest film manifestations of 73 PSS patients which have been subgrouped. Radiographic abnormalities, either interstitial lung disease or pleural effusion, were present as follows: PSS, 18% (8/44); CRST/CREST, 0% (0/9); and PSS-overlap, 75% (15/20). Interstitial lung diseases in the PSS-overlap group was usually basilar and of mild severity on the initial chest film obtained. While the classic PSS group had a very much lower incidence of lung disease, it was usually more diffuse and severe.

Entities:  

Mesh:

Year:  1981        PMID: 6789634     DOI: 10.2214/ajr.137.2.277

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  7 in total

Review 1.  Imaging of the pulmonary manifestations of systemic disease.

Authors:  A G Rockall; D Rickards; P J Shaw
Journal:  Postgrad Med J       Date:  2001-10       Impact factor: 2.401

Review 2.  Lung involvement in systemic sclerosis.

Authors:  Paul M Hassoun
Journal:  Presse Med       Date:  2010-12-30       Impact factor: 1.228

3.  Meigs' syndrome: a rare cause of recurrent pleural effusion in scleroderma.

Authors:  Feng Su; Kristopher W Cummings; Hannah Krigman; Prabha Ranganathan
Journal:  Rheumatol Int       Date:  2012-04-27       Impact factor: 2.631

Review 4.  Scleroderma lung disease.

Authors:  Joshua J Solomon; Amy L Olson; Aryeh Fischer; Todd Bull; Kevin K Brown; Ganesh Raghu
Journal:  Eur Respir Rev       Date:  2013-03-01

5.  Scleroderma lung disease.

Authors:  Jérôme Le Pavec; David Launay; Stephen C Mathai; Paul M Hassoun; Marc Humbert
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

Review 6.  Pictorial review of intrathoracic manifestations of progressive systemic sclerosis.

Authors:  Hamdan Al-Jahdali; Prabhakar Rajiah; Carolyn Allen; Shyam Sunder Koteyar; Ali Nawaz Khan
Journal:  Ann Thorac Med       Date:  2014-10       Impact factor: 2.219

7.  Fatal consequences of therapeutic thoracentesis in patients with systemic sclerosis.

Authors:  Tsvi Sirotkin; Aiman Natour; Ori Wand; Yair Levy
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-09-30       Impact factor: 0.670

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.